Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs.

Abstract

Tuberculosis is rising in the developing world due to poor health care, human immunodeficiency virus type 1 infection, and the low protective efficacy of the Mycobacterium bovis BCG vaccine. A new vaccination strategy that could protect adults in the developing world from tuberculosis could have a huge impact on public health. The auathors show that BCG boosted by poxviruses expressing antigen 85A induced unprecedented 100% protection of guinea pigs from high-dose aerosol challenge with Mycobacterium tuberculosis, suggesting a strategy for enhancing and prolonging the efficacy of BCG.

Citation

Williams, A.; Goonetilleke, N.P.; McShane, H.; Clark, S.O.; Hatch, G.; Gilbert, S.C.; Hill, A.V.S. Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs. Infection and Immunity (2005) 73 (6) 3814-3816. [DOI: 10.1128/IAI.73.6.3814-3816.2005]

Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.